Applying a phase II futility study design to therapeutic stroke trials

  • Palesch Y
  • Tilley B
  • Sackett D
 et al. 
  • 32


    Mendeley users who have this article in their library.
  • 40


    Citations of this article.


Most large, randomized phase III efficacy trials of therapeutic agents in ischemic stroke have failed to find treatment benefit. We determined whether some phase III studies could have been avoided if preceded by smaller single-arm phase II studies to evaluate the futility of proceeding to phase III.

Author-supplied keywords

  • Clinical trials, phase II
  • Ischemia
  • Stroke

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Yuko Y. Palesch

  • Barbara C. Tilley

  • David L. Sackett

  • Karen C. Johnston

  • Robert Woolson

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free